Medically reviewed by: Jayden Lee, PharmD, EMBA Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes
Importantly, no severe treatment-related adverse effects were documented across any trial
ALL OUR LYOPHILIZED PEPTIDES ARE FOR RESEARCH USE ONLY
Both principal degradants retain some in vitro anti-lipogenic activity, suggesting partial preservation of biological function through the oral digestion process
Investigated effect 2: Adipocyte lipid handling
Start with doses at the lower end of the dosing range